Complete Report Title “Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021) (By Drug Class -Endothelin Receptor Antagonists, Prostacyclin & Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others; By Region-North America, Europe, APAC, Latin America, MEA; By Country- USA, Canada, UK, Germany, Japan, Brazil, South Africa)” Available at RnRMarketResearch.com Store for US $2400.
Pune, India-- (SBWIRE) -- 08/16/2016 -- Global Pulmonary Arterial Hypertension Market: Trends, Opportunities and Forecasts (2016-2021), Global Pulmonary Arterial Hypertension market is projected to exhibit a CAGR of over ~4.95% during 2016 - 2021. On the basis of market segment, Global Pulmonary Arterial Hypertension Market has been segmented By Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others; By Region-North America, Europe, APAC, Latin America, MEA; By Country- USA, Canada, UK, Germany, Japan, Brazil, South Africa)
141 Pages Report is Available at http://www.rnrmarketresearch.com/global-pulmonary-arterial-hypertension-pah-market-by-drug-class-by-region-by-country-opportunities-and-forecasts-2016-2021-by-drug-class-endothelin-receptor-antagonists-prostacyclin-prostacyclin-analog-th-africa-market-report.html.
Scope of the Report
The report provides Segmentation by Drug Class
Endothelin receptor antagonists, Prostacyclin and Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others
The report provides coverage by Region
North America, Europe, Asia Pacific, Latin America, Middle East and Africa (MEA)
The report provides coverage by Country
USA, Canada, UK, Germany, Japan, Brazil, South Africa
Directly Purchase a Single User Copy of Report at http://www.rnrmarketresearch.com/contacts/purchase?rname=664277.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of the global Pulmonary Arterial Hypertension (PAH) market on the basis of Drug Class (Endothelin Receptor Antagonists, Prostacyclin, Prostacyclin Analogs, Phosphodiesterase V Inhibitors, Others), By Region (North America, Europe, APAC, Latin America, MEA) and By Country (USA, Canada, UK, Germany, Japan, Brazil, South Africa).
The report suggests that rising development of pipeline drugs in PAH combined with the growing awareness of the disease majorly in developed countries has resulted in the growth of PAH market. Also, the market for Pulmonary Arterial Hypertension (PAH) is growing moderately due to newer launches of pipeline drugs that target different pathways to supress the symptoms of the disease. Early diagnosis of the disease has played a pivotal role in number of patients undergoing treatment.
Among the drug classes, the market is expected to be driven by ERAs. However, growing number of drugs under prostacyclin are expected to witness tremendous growth in the forecast period.
While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population. Global Pulmonary Arterial Hypertension Market is forecasted to grow at a CAGR of 4.95% during 2016 – 2021F, on account of rising prevalence of the PAH disease among the population.
North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by the countries such as India and China.
Check for DISCOUNT at http://www.rnrmarketresearch.com/contacts/discount?rname=664277.
Table of Contents
Global PAH Market: An Overview
North America PAH Market: An Overview
Europe PAH Market: An Overview
APAC PAH Market: An Overview
Latin America PAH Market: An Overview
MEA PAH Market: An Overview
Policy and Regulatory Landscape
M&A and Licensing Route to the PAH Market
Porter Five Force Model
Competitive Market Share Analysis
List of Tables And Figures
Table 1: Prostacylin – Pipeline Drugs
Table 2: ERA – Pipeline Drugs
Table 3: PDA 5 Inhibitor – Pipeline Drugs
Table 4: PAH – Pipeline Drugs (Phase I & II)
Table 5: PAH – Pipeline Drugs (Phase III)
Table 6: Mergers and Acquisitions in PAH Market
Table 7: Licensing Agreements in PAH Market
Figure 1: Global PAH Market, 2011-2015 (USD Billion)
Figure 2: Types of pulmonary arterial hypertension
Figure 3: PAH Associated With Other Diseases (APAH)
Figure 4: Global PAH Market, 2016E-2021F (USD Billion)
RnRMarketResearch.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.